| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/30/2009 | CN101543518A Ginseng stem leaf total sapogenin oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543517A Folium ginkgo total flavonoid aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543515A Preparation method of super-micro aurantii immaturi and atractylodis pills |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543501A Balsatazide sodium enema liquid and preparation method thereof |
| 09/30/2009 | CN101543492A Novel application of dendrobine |
| 09/30/2009 | CN101543491A Application of m-chlorobenzoyl substituted dehydrosilybin for preparing antiviral drugs |
| 09/30/2009 | CN101543480A Tablets |
| 09/30/2009 | CN101543474A Lansoprazole sodium submicron emulsion freeze-drying preparation |
| 09/30/2009 | CN100544737C Use of selaginella tamariscina for preparing medicine for treating gastrosia and its Chinese medicine composition |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use |
| 09/29/2009 | US7595329 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; gastroesophageal reflux disease, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 09/29/2009 | US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 09/29/2009 | US7595301 Staple type oligonucleotide and drug comprising the same |
| 09/29/2009 | US7595299 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/29/2009 | CA2521391C Potassium salt of s-omeprazole as intermediate in the preparation of the magnesium salt of s-omeprazole trihydrate |
| 09/29/2009 | CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2434009C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 09/29/2009 | CA2394079C Weight promoting composition, method and product |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/29/2009 | CA2375670C 5-phenyl-pyrimidine derivatives |
| 09/29/2009 | CA2347105C Controlled-release pharmaceutical composition with gastric residence |
| 09/29/2009 | CA2334923C Aryl substituted olefinic amines and their use as cholinergic receptors agonists |
| 09/29/2009 | CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/29/2009 | CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas |
| 09/29/2009 | CA2313372C Composition and method for prolonging the useful life of enteral feeding tubes |
| 09/29/2009 | CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/24/2009 | WO2009116887A1 Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy |
| 09/24/2009 | WO2009116886A1 Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics |
| 09/24/2009 | WO2009115398A1 Vitamin d compounds for the treatment of biliary diseases |
| 09/24/2009 | WO2009115321A1 Midazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| 09/24/2009 | WO2009115280A1 Remineralizing saliva substitute and method for the production thereof |
| 09/24/2009 | WO2009115272A1 Remineralizing dental care product and method for the production thereof |
| 09/24/2009 | WO2009115023A1 A anthocyanins phospholipid complex and the preparative method thereof |
| 09/24/2009 | WO2009114981A1 Process for preparing sulfoxide compounds |
| 09/24/2009 | WO2009087285A4 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 09/24/2009 | WO2009053443A3 Indane compounds |
| 09/24/2009 | WO2009049013A3 Cholera vaccines |
| 09/24/2009 | WO2009039248A3 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 09/24/2009 | WO2008144423A3 Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer |
| 09/24/2009 | US20090239919 Glutamate receptor modulators and therapeutic agents |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239823 Foods and drinks having health benefits and method for adding health benefits to foods and drinks |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239295 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/24/2009 | US20090239265 Virus like particles |
| 09/24/2009 | US20090238843 Recombinant mva capable of expressing structural hcv antigens |
| 09/24/2009 | US20090238803 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 09/24/2009 | US20090238796 Preparation for treatment of non-infectious inflammatory intestinal diseases |
| 09/24/2009 | US20090238795 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 09/24/2009 | US20090238777 High Fluoride Ion Recovery Compositions |
| 09/24/2009 | US20090238774 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| 09/24/2009 | CA2718558A1 Midazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as_melanocortin-4 receptor modulators |
| 09/23/2009 | EP2103684A1 Vascularisation enhanced graft constructs |
| 09/23/2009 | EP2103624A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/23/2009 | EP2103614A1 Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| 09/23/2009 | EP2103612A1 Crystalline forms of palonosetron hydrochloride |
| 09/23/2009 | EP2103608A1 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion |
| 09/23/2009 | EP2103312A1 Preparation for sterilization or disinfection of tissue |
| 09/23/2009 | EP2103306A2 Use of a 5'-nucleotide for preventing/improving functional digestive disorder |
| 09/23/2009 | EP2102202A2 Conglomerates of tenatoprazole potassium salts |
| 09/23/2009 | EP2102192A1 Solid state forms of racemic ilaprazole |
| 09/23/2009 | EP2102191A1 Crystalline forms of solvated ilaprazole |
| 09/23/2009 | EP2101811A2 Vaccine for periodontitis and methods of use |
| 09/23/2009 | EP2101810A2 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 09/23/2009 | EP2101809A1 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 09/23/2009 | EP1482928B1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
| 09/23/2009 | CN101538550A Helicobacter pylori viable bacteria carrier vaccine and special recombination bacteria thereof |
| 09/23/2009 | CN101538537A Pestalotiopsis fici and discovery and application of generated anti-tumor active compounds thereof |
| 09/23/2009 | CN101538520A Tricholoma matsutake wine |
| 09/23/2009 | CN101538326A Variable region sequence of hepatitis B virus monoclonal antibody, gene engineering antibody containing variable region and application thereof |
| 09/23/2009 | CN101538311A Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof |
| 09/23/2009 | CN101538304A Fungi mixture and method for preparing same |
| 09/23/2009 | CN101538303A Natural fatty acid monoester derivatives of cucurbitacin monomers |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538245A One-class pyridazinone compounds and preparation method and application thereof |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101538218A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 09/23/2009 | CN101537182A Combination comprising an HMG CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 09/23/2009 | CN101537166A Traditional Chinese medicine for curing pregnancy pernicious vomiting |
| 09/23/2009 | CN101537165A Chinese traditional medicine preparation for curing colon cancer |
| 09/23/2009 | CN101537160A Health product for toxicant elimination and beauty maintenance |
| 09/23/2009 | CN101537159A Traditional Chinese medicine composition and preparation method and application thereof |
| 09/23/2009 | CN101537156A Chinese herbal medicine composite capable of curing stomach illness and duodenal ulcer disease |
| 09/23/2009 | CN101537154A Manufacturing method of medicament for treating ten kinds of diseases |
| 09/23/2009 | CN101537151A Pharmaceutical composition having effects of alleviating alcoholism, protecting liver, invigorating stomach and clearing bowels |
| 09/23/2009 | CN101537146A Chinese medicine for treating carcinoma of colon |
| 09/23/2009 | CN101537145A Traditional Chinese medicinal composition for treating ruminant fore-stomach stony indigestion, preparation method and applications thereof |
| 09/23/2009 | CN101537144A Chinese material medical preparation for treating esophagus cancer and gastric cancer of digestive system |
| 09/23/2009 | CN101537143A Chinese traditional medicine composition for curing chronic gastritis and preparation method thereof |
| 09/23/2009 | CN101537142A Invigorating spleen colon pulvis |
| 09/23/2009 | CN101537139A Chinese traditional medicine preparation for treating hepatitis and preparation method thereof |
| 09/23/2009 | CN101537138A Traditional Chinese medicine hepatitis B powder for eliminating duplication of hepatitis B virus (HBV) and method for manufacturing same |
| 09/23/2009 | CN101537134A Chinese traditional medicine preparation for curing ascites due to cirrhosis |
| 09/23/2009 | CN101537122A Chinese traditional medicine composition for curing constipation and preparation method thereof |